Skip to content
healthcare.dev

LISINOPRIL

NDC 76282-731, LISINOPRIL, tablet, from Exelan Pharmaceuticals, Inc.

Product NDC
76282-731
Status
Listed
Labeler
Exelan Pharmaceuticals, Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076102
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-731 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISINOPRIL20 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]

Package NDCNDC-11Package
76282-731-0176282073101100 TABLET in 1 BOTTLE (76282-731-01)
76282-731-0576282073105500 TABLET in 1 BOTTLE (76282-731-05)
76282-731-10762820731101000 TABLET in 1 BOTTLE (76282-731-10)
76282-731-1876282073118180 TABLET in 1 BOTTLE (76282-731-18)
76282-731-307628207313030 TABLET in 1 BOTTLE (76282-731-30)
76282-731-457628207314545 TABLET in 1 BOTTLE (76282-731-45)
76282-731-50762820731505000 TABLET in 1 BOTTLE (76282-731-50)
76282-731-907628207319090 TABLET in 1 BOTTLE (76282-731-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4aad4d30-3e18-489c-80ad-ccf7532bb933
  • NADAC price for package 76282073101

    GET /v1/drugs/nadac/76282073101
  • NADAC price for package 76282073110

    GET /v1/drugs/nadac/76282073110
  • NADAC price for package 76282073118

    GET /v1/drugs/nadac/76282073118
  • NADAC price for package 76282073145

    GET /v1/drugs/nadac/76282073145
  • NADAC price for package 76282073150

    GET /v1/drugs/nadac/76282073150
  • NADAC price for package 76282073190

    GET /v1/drugs/nadac/76282073190

Use it

Look up 76282-731 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-731 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.